Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Prexton Therapeutics’ Parkinson’s Assets First to Emerge from Merck KGAA Restructuring

Aug 01 2012

Related Content

Merck KGAA Begins Transformation Effort By Closing Geneva Site

Apr 25 2012

Merck Serono Ventures, Compugen Team Up On Drug Toxicity Biomarker Start-Up

Jun 26 2012

Positive Early Results For Addex Parkinson’s Drug Dipraglurant Spur Hopes For Deal

Mar 22 2012

Merck Serono Builds $54M VC Bridge Over Troubled Waters

Mar 24 2009

Related Companies

Merck KGaA

Merck KGaA

GSK plc

Addex Therapeutics Ltd

Compugen Ltd.

Neviah Genomics Ltd

Additional Topics

Germany Europe Switzerland Business Strategies BioPharmaceutical

More from Germany

More from Europe

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window